Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimel Manuka honey eye drops for allergic conjunctivitis
NCT03862053Phase 4Withdrawn
- Sponsor
- Toyos Clinic
- Start
- Jan 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of manuka honey in allergic conjunctivitis (AC), sponsored by Toyos Clinic. Primary endpoint: Subject-assessed ocular itching at 7 weeks. Planned start Jan 2020; status: withdrawn.
02
Drugs
manuka honey
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT03862053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862053.